Characteristics | Controls | INR | IR | p-value (IR vs INR) |
---|---|---|---|---|
Number of subjects | 18 | 10 | 10 | Â |
Male (%) | 100 | 100 | 100 | Â |
Age (years) | 37 (35, 38) | 33 (29, 49) | 39 (30, 43) |  > 0.05 |
Body mass index (kg/m2) | 23 (20.3, 23.0) | 21.7 (20.6, 22.8) | 21.5 (20.9, 21.9) |  > 0.05 |
Glucose (mmol/L) | NA | 5.3 (4.5, 5.6) | 5.0 (4.9, 5.4) |  > 0.05 |
AST (U/L) | NA | 26.5 (23.8, 30.2) | 24.6 (23.0, 37.0) |  > 0.05 |
ALT (U/L) | NA | 26.5 (20.3, 35.0) | 31.0 (19.0, 50.0) |  > 0.05 |
Triglyceride (mmol/L) | NA | 1.23 (1.00, 1.33) | 1.28 (1.09, 1.79) |  > 0.05 |
Total cholesterol (mmol/L) | NA | 3.44 (3.36, 3.90) | 4.06 (3.56, 4.28) |  > 0.05 |
Viral load (copies/mL) | NA |  < 20 |  < 20 |  |
CD4+ T cell count (cells/μL) |  |  |  |  |
Baseline | NA | 162 (95, 179) | 97 (79, 154) |  > 0.05 |
At 2 years of ART | NA | 219 (163, 234) | 456 (383, 510) |  < 0.05 |
Drug regimen | ||||
 EFV + 3TC + AZT | NA | 2 | 1 |  > 0.05 |
 EFV + 3TC + TDF | NA | 1 | 1 | |
 NVP + 3TC + AZT | NA | 7 | 8 |